Discover the Best Stocks and Maximize Your Portfolio:
- See what stocks are receiving strong buy ratings from top-rated analysts.
- Filter, analyze, and streamline your search for investment opportunities with TipRanks’ Stock Screener.
Dr Reddy’s Laboratories ( (RDY) ) has issued an update.
On February 5, 2025, Dr. Reddy’s Laboratories announced that its management will participate in an investor conference organized by Nirmal Bang Institutional Equities on February 12, 2025. This virtual group meeting is expected to enhance engagement with institutional investors and analysts, reflecting the company’s proactive approach to investor relations and transparency.
More about Dr Reddy’s Laboratories
Dr. Reddy’s Laboratories is a multinational pharmaceutical company based in Hyderabad, India. It specializes in the manufacture and distribution of pharmaceutical products, active pharmaceutical ingredients, and biotechnology products. The company focuses on providing affordable and innovative medicines to patients globally, with a significant presence in international markets.
YTD Price Performance: -11.68%
Average Trading Volume: 1,608,353
Technical Sentiment Consensus Rating: Buy
Current Market Cap: $11.52B
For detailed information about RDY stock, go to TipRanks’ Stock Analysis page.
